Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03040986
Brief Title: Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations

First Submitted : February 1, 2017
First Submitted that Met QC Criteria : February 1, 2017
First Posted : February 2, 2017 (Estimate)

Results First Submitted : October 18, 2020
Results First Submitted that Met QC Criteria : December 16, 2020
Results First Posted : January 11, 2021

Last Update Submitted that Met QC Criteria : January 20, 2021
Last Update Posted : February 9, 2021